Employees and Directors [Member]
Employees and directors
Represents information pertaining to employees and directors.
License Agreement Disclosure [Text Block]
LICENSE AGREEMENT
The entire disclosure for a license agreement between one or more parties.
Number of development milestones required
Represents the number of development milestones required under the agreement.
Number of Development Milestone Achievement Required
Represents the potential payment to extend the term of the license agreement.
License Extension Potential Payment
Potential extension payment
Term of extension of the agreement
Collaborative Arrangement Extension Term
Represents the term of extension of the collaborative agreement.
Foreign exchange effect on Euro denominated notes
Debt Instrument Effect of Exchange Rate
Amount of effect of exchange rate changes on debt balances held in foreign currencies.
Period [Axis]
Represents the information or schedule of various period.
Period [Domain]
Represents the details of various period.
Period One [Member]
Period one
Period one representing most current period under terms of an agreement.
Amendment Description
Period Two [Member]
Period two
Period two representing second most current period under terms of an agreement.
Amendment Flag
Share of aggregate development cost following completion of Phase Ib clinical trials and animal toxicology studies
Aggregate Development Costs
Represents the aggregate development costs.
Nonrecourse Note [Member]
Nonrecourse note
Represents information pertaining to nonrecourse note.
Stockholders Equity [Line Items]
Stockholder's equity
Debt Instrument Maximum Borrowing Capacity
Maximum drawdown amount
Represents the amount of maximum borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.
Debt Default Interest Rate
Interest rate under terms of default (as a percent)
Represents the interest rate for funds borrowed under terms of default.
Percentage multiplied to price per share paid by the Investors for each share of common stock to determine conversion price
Represents the percentage multiplied to price per share paid by the investors for each share of common stock to determine conversion price.
Debt Instrument Percentage Multiplied to Share Price to Determine Conversion Price
Amount of Gross Proceeds to be Received for Defining Transaction as Qualified Financing
Amount of gross proceeds to be received for defining transaction as qualified financing
Represents the amount of gross proceeds to be received for defining transaction as qualified financing.
Agreement with Quotient Ltd [Member]
Agreement with Quotient Ltd
Represents information pertaining to agreement with Quotient Ltd.
Base salary
Base Salary of Employee
Represents the base salary of an employee.
Aggregate salaries
Percentage of Bonus on Base Salary of Employee
Percentage of bonus on base salary
Represents the percentage of bonus on base salary of payable to an employee.
Annual bonus target, as percentage of annual salaries
Bonus Special Employee
Special bonus
Represents the amount of special or one-time bonus payable to an employee.
One-time bonus
Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Percent Outstanding Shares
Percentage of outstanding common stock for which option is granted
The percentage of outstanding shares for which the share option, which is granted during the period, may purchase.
NATURE OF OPERATIONS AND LIQUIDITY
Nature of Operations and Liquidity [Table]
Disclosure pertaining to nature of operations and liquidity.
Mind NRG [Member]
Mind-NRG
Represents information pertaining to Mind-NRG.
Nature of Operations and Liquidity [Line Items]
Nature of operations and liquidity
Current Fiscal Year End Date
Accrued Expenses and Other Liabilities [Table]
Disclosure pertaining to accrued expenses and other liabilities.
Proteo Sys AG [Member]
ProteoSys
Represents information relating to ProteoSys AG.
Accrued Expenses and Other Liabilities [Line Items]
Accrued expenses and other liabilities
Accrued Research and Development Costs Current
Research and development costs
Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for research and development costs. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer).
Accrued Research Funding Current
Primomed research funding
Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for research funding. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer).
Accrued Consulting and Other Costs Current
Consulting and other costs
Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for consulting and other costs. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer).
Award Type [Axis]
Cost incurred in connection with the preparation of a public offering of the Company's common stock included in accrued professional fees
Represents the carrying value, as of the balance sheet date, of obligations incurred through that date and payable for public offering costs. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle, if longer).
Accrued Public Offering Costs Current
Accrued Expenses and Other Liabilities Current
Accrued expenses and other liabilities
Total of the carrying values, as of the balance sheet date, of obligations incurred through that date and payable for obligations related to accrued expenses and other costs not separately disclosed in the balance sheet. It is used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Equity financing obligation
Represents the amount of equity financing obligation.
Equity Financing Obligation
Common stock options
An arrangement whereby an employee and non-employee are entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement.
Stock Option
Employee and Non Employee Stock Option [Member]
Document Period End Date
Deferred public offering costs included in accrued expenses and other liabilities
Public Offering Costs Incurred but not Yet Paid
Future cash outflow to pay for public offering costs that have occurred.
Employment Contract [Member]
Employment contract
Contracts securing the services of employees.
Significant risks and uncertainties
Disclosure of accounting policy for significant risks and uncertainties.
Significant Risks and Uncertainties [Policy Text Block]
Income Taxes [Abstract]
Income taxes
Goodwill [Abstract]
Goodwill
Sonkei [Member]
Sonkei
Represents information pertaining to Sonkei.
Nonemployee Holding Common Stock With Nonrecourse Note [Member]
Non-employee holding common stock with nonrecourse note
Represents information relating to non-employee holding common stock with nonrecourse note.
Business Acquisition Number of Shares Held in Escrow
Number of shares held in escrow
Represents the number of shares held in escrow in business combination.
Share Based Compensation Arrangement by Share Based Payment Award Number of Shares Held
Number of shares held
Represents the number of shares held under share-based compensation.
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Other Assets
Other Assets
Represents the amount of other assets (as defined) recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Deferred Tax Liabilities
Deferred tax liability
Represents the amount of deferred tax liabilities assumed (as defined) which have been recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Accrued Expenses
Accrued expenses
Represents the amount of accrued expenses assumed (as defined) which have been recognized as of the acquisition date.
Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Milestone Payable
Milestone payable
Represents the amount of milestone payable assumed (as defined) which have been recognized as of the acquisition date.
ProteoSys milestone payable
The amount of milestone payables that the Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition.
Noncash or Part Noncash Acquisition Milestone Payables Assumed
ProteoSys milestone payable
The amount of deferred tax liability that the Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition.
Noncash or Part Noncash Acquisition Deferred Tax Liability Assumed
Deferred tax liability
Noncash or Part Noncash Acquisition Prepaid Expense Acquired
Prepaid expenses
The amount of prepaid expenses that the Entity acquires in a noncash (or part noncash) acquisition.
Noncash or Part Noncash Acquisition Goodwill Acquired
Goodwill
The amount of goodwill that the Entity acquires in a noncash (or part noncash) acquisition.
Cash Acquired in Business Merger
Cash acquired in business merger
Represents the amount associated with the acquisition of a business when the cash held by the acquired business exceeds the cash payments to acquire the business.
CO-DEVELOPMENT AND LICENSE AGREEMENT
Common Stock Purchase Agreement [Member]
Common stock purchase agreement
Represents information pertaining to the common stock purchase agreement entered into by the entity.
MIN 202 [Member]
MIN-202
Represents information pertaining to MIN-202.
Arrangements and Non-arrangement Transactions [Domain]
Percentage of Development Costs Related to Joint Development of Products
Percentage of development costs related to joint development of products
Represents the percentage of development costs related to joint development of any products for which the entity is responsible.
Period within which Agreement is Terminated
Period within which agreement is terminated related to Phase Ib clinical trials milestone
Represents the period within which the entity terminates the agreement.
Fees for Termination of Agreement
Termination fees related to Phase Ib clinical trial milestone
Represents the amount of fees related to termination of the agreement.
LICENSE AGREEMENT
License Agreement [Member]
License Agreement
Represents information pertaining to the license agreement entered into by the entity.
Represents information pertaining to MIN-101.
MIN 101 [Member]
MIN-101
MIN 117 [Member]
MIN-117
Represents information pertaining to MIN-117.
Mitsubishi Tanabe Pharma Corporation [Member]
Mitsubishi
Represents information pertaining to Mitsubishi Tanabe Pharma Corporation ("Mitsubishi").
Potential Milestone Payments upon Achievement of Milestone
Represents the amount of potential milestone payments that will be made upon the achievement of certain milestones under the agreement.
Potential milestone payments upon achievement of milestone
Share Based Compensation Arrangement by Share Based Payment Award Options Grants in Period Percent Fully Diluted Outstanding Shares
Percentage of fully diluted outstanding common stock for which option is granted
The percentage of fully diluted outstanding shares for which the share option, which is granted during the period, may purchase.
Percentage of fully diluted shares for which holders have options to purchase aggregate number of common shares
Stockholders [Member]
Certain stockholders
Represents information pertaining to stockholders.
Related Party Transaction Accounting and Other Services Expenses Per Year
Accounting and other services expenses per year
Represents the amount of accounting and other services expenses incurred in transaction with related party per year.
Represents the number of agreements entered into by the entity.
Number of Agreements
Number of agreements
Period Allowed under Agreement for Payment Maximum
Period allowed to pay bonus following closing of an IPO
Represents the maximum period allowed under an agreement to make the required payment.
Period of Notice for Termination
Period of notice for termination of agreement
Represents the period of notice for termination of an agreement.
Shares Authorized
Total number of authorized shares
The maximum number of common and preferred shares permitted to be issued by the entity's charter and bylaws.
Schedule of Common Shares Issued in Exchange for Nonrecourse Notes [Table Text Block]
Summary of common shares issued in exchange for nonrecourse notes
Tabular disclosure of common shares issued in exchange for nonrecourse notes payable that are being accounted for as stock options.
Disclosure for stockholders equity.
Stockholders Equity [Table]
Share Based Compensation Arrangement by Share Based Payment Award Options Exercisable Value
Exercise price of stock options
Represents the amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
Number of Nonvested Stock Upon Conversion of Stock Options
Number of non-vested stock upon conversion of stock option (in shares)
Represents the number of non-vested stock upon conversion of stock options.
Nonvested Stock Upon Conversion of Stock Options Exercisable Value
Exercise price of non-vested stock
Represents the amount of exercisable non-vested stock upon conversion of stock options.
Document Entity Information [Abstract]
Co Development Licensor [Member]
Co-development licensor
Represents information relating to the counterparty licensor to the agreement.
Payments of License Fees
Payments of License Fees
Represents the amount of cash outflow for license fees paid during the period.
License Fee Payable
Initial upfront license fee payable
Represents the amount due in accordance to the license agreement.
April Bridge Loan [Member]
April Bridge Loan
Represents information pertaining to April Bridge Loan.
May Bridge Loan [Member]
May Bridge Loan
Represents information pertaining to May Bridge Loan.
Gross Proceeds from Issuance of Common Stock
Aggregate proceeds from sale of common stock
Represents the gross proceeds received from the issuance of common stock during the period.
Underwriting Discount
Underwriting discount
Represents the amount of underwriting discount incurred during the period.
Non Vested Stock Issued [Member]
Non-vested stock issued
Represents information pertaining to non-vested stock issued by the entity.
Stock Option Fully Vest IPO [Member]
Stock Options - fully vest upon IPO
An arrangement whereby a number of shares in the entity at a specified price, as defined in the agreement that fully vest upon the effective date of the entity's registration statement.
Vesting Period [Axis]
Information by vesting period pertaining to shares issued under equity-based compensation plans.
Entity Well-known Seasoned Issuer
Vesting Period [Domain]
Vesting period for the shares issued under equity-based compensation plans.
Entity Voluntary Filers
Award vested on grant date
Represents information pertaining to awards vested on date of grant.
Award Vested on Grant Date [Member]
Entity Current Reporting Status
Award Vested Over Four Year Beginning from November 12 2013 [Member]
Award vested over four year period beginning November 12, 2013
Represents information pertaining to awards vested over four year period beginning November 12, 2013.
Entity Filer Category
Noncash or Part Noncash Acquisition, Intangible Assets Other Than Goodwill Acquired
The amount of intangible assets, other than goodwill, that the entity acquires in a noncash (or part noncash) acquisition.
In-process research and development
Entity Public Float
Business Acquisitions Equity Interests Issued or Issuable Share Ratio
Conversion ratio
Ratio applied to the stock of the acquired company, for example but not limited to, one share converted to two or two shares converted to one.
Entity Registrant Name
Underwriting Discount on Issuance Initial Public Offering
Underwriter discount
Represents the amount of underwriting discount incurred on issuance of shares in initial public offering during the period.
Entity Central Index Key
Entity Common Stock, Shares Outstanding
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Type
SIGNIFICANT ACCOUNTING POLICIES
ACCRUED EXPENSES AND OTHER LIABILITIES
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Accounts payable
Accounts Payable, Current
Vacation pay
Accrued Vacation, Current
Accrued expenses and other current liabilities
Accrued Liabilities, Current
Bonus
Accrued Bonuses, Current
Professional fees
Accrued Professional Fees, Current
Additional paid-in capital
Additional Paid in Capital, Common Stock
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Stock-based compensation
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense (in dollars)
Allocated Share-based Compensation Expense
Stock based compensation expense
Amortization of Debt Discount (Premium)
Amortization of debt discount recorded as interest expense
Amortization of the debt discount
Antidilutive Securities [Axis]
Securities outstanding excluded from the calculation of weighted average shares outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities, Name [Domain]
Securities outstanding excluded from the calculation of weighted average shares outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Total assets
Assets
Current assets
Assets, Current [Abstract]
Assets
Assets [Abstract]
Total current assets
Assets, Current
Basis of presentation
Basis of Accounting, Policy [Policy Text Block]
Loss per share (in dollars per share)
Business Acquisition, Pro Forma Earnings Per Share, Basic
Business Acquisition [Axis]
Unaudited pro forma financial information
Business Acquisition, Pro Forma Information [Abstract]
Estimated fair value (in dollars per share)
Business Acquisition, Share Price
Cash
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Schedule of unaudited pro forma financial information
Business Acquisition, Pro Forma Information [Table Text Block]
Intangible assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets
Operating loss
Business Acquisition, Pro Forma Income (Loss) from Continuing Operations before Changes in Accounting and Extraordinary Items, Net of Tax
Aggregate consideration
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
BUSINESS COMBINATIONS
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired
Share capital acquired (as a percent)
Voting interest (as a percent)
Business Acquisition, Acquiree [Domain]
BUSINESS COMBINATIONS
Number of shares of common stock
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
Derivative liability
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities
BUSINESS COMBINATIONS
Business Combination Disclosure [Text Block]
Business combinations
Business Combinations Policy [Policy Text Block]
Assets acquired and liabilities assumed based on estimated fair values
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Total
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
Counterparty Name [Axis]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value [Abstract]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Beginning of period
End of period
Cash Acquired from Acquisition
Cash acquired in business combination
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosure of noncash investing and financing activities
CEO
Chief Executive Officer [Member]
Co-development and license agreement
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
License Agreement
Co-development and license agreement
Collaborative Arrangement [Member]
CO-DEVELOPMENT AND LICENSE AGREEMENT
Collaborative Arrangement Disclosure [Text Block]
COMMITMENTS
Commitments and contingencies
Commitments and Contingencies
COMMITMENTS
Commitments and Contingencies Disclosure [Text Block]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common Stock [Member]
Common Stock
Common stock; $.0001 par value; 125,000,000 shares authorized; 8,520,925 and 6,112,738 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively
Common Stock, Value, Issued
Common stock, shares issued
Common Stock, Shares, Issued
Common stock, shares authorized
Common Stock, Shares Authorized
Common stock agreed to be issued (in shares)
Common Stock, Shares Subscribed but Unissued
Common Stock, Capital Shares Reserved for Future Issuance
Number of shares of common stock reserved for issuance
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Outstanding at the beginning of the period (in shares)
Outstanding at the end of the period (in shares)
Consolidation
Consolidation, Policy [Policy Text Block]
Total cost of the project
Contractual Obligation
Common stock issued upon conversion (in shares)
Conversion of Stock, Shares Issued
Convertible promissory notes
Convertible Notes Payable [Member]
Convertible Promissory Notes
Schedule of convertible promissory notes and debt discount
Convertible Debt [Table Text Block]
Convertible promissory notes
Convertible Notes Payable, Current
Convertible promissory notes, net
Carrying value of convertible promissory notes
Convertible promissory notes (see Note 7)
Face value
Debt Instrument, Face Amount
Principal amount
Face amount
DEBT
Convertible promissory notes
Long-term Debt, Gross
DEBT
Debt Disclosure [Text Block]
Conversion price (in dollars per share)
Debt Instrument, Convertible, Conversion Price
Debt discount
Debt Instrument, Unamortized Discount
Debt discount
Interest rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Convertible promissory notes
Debt, Policy [Policy Text Block]
Fair value of convertible promissory notes
Debt Instrument, Fair Value Disclosure
Deferred public offering costs
Deferred Charges, Policy [Policy Text Block]
Deferred public offering costs
Deferred Finance Costs, Noncurrent, Net
Deferred taxes
Deferred Tax Liabilities, Net, Noncurrent
Depreciation, Depletion and Amortization
Depreciation and amortization
Derivative liability
Derivative Liability, Current
STOCK OPTION PLAN
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
STOCK OPTION PLAN
Expenses due to related parties
Due to Related Parties, Current
Net loss per share of common stock - basic and diluted (in dollars per share)
Earnings Per Share, Basic and Diluted
Net loss per share, basic and diluted (in dollars per share)
NET LOSS PER SHARE OF COMMON STOCK
Earnings Per Share [Text Block]
Loss per share
Earnings Per Share, Policy [Policy Text Block]
NET LOSS PER SHARE OF COMMON STOCK
Embedded Derivative, Loss on Embedded Derivative
Decrease in fair value of the derivative liability
Fair value of derivative liability
Embedded Derivative, Fair Value of Embedded Derivative Liability
Total unrecognized compensation costs related to non-vested awards (in dollars)
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
Period over which unrecognized compensation costs related to non-vested awards is expected to be recognized
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Equity Component [Domain]
Total
Estimate of Fair Value Measurement [Member]
Liability Class [Axis]
Discount rate (as a percent)
Fair Value Inputs, Discount Rate
Recurring basis
Fair Value, Measurements, Recurring [Member]
Fair Value by Liability Class [Domain]
Measurement Frequency [Axis]
Fair Value, Hierarchy [Axis]
Fair Value Measurements, Recurring and Nonrecurring [Table]
Remaining term
Fair Value Assumptions, Expected Term
Fair Value, Measurement Frequency [Domain]
Fair value of financial instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Hierarchy [Domain]
Level 2
Fair Value, Inputs, Level 2 [Member]
Level 1
Fair Value, Inputs, Level 1 [Member]
Level 3
Fair Value, Inputs, Level 3 [Member]
Schedule of liabilities measured at fair value on a recurring basis
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets by Major Class [Axis]
Foreign exchange gains
Foreign Currency Transaction Gain (Loss), before Tax
General and administrative
General and Administrative Expense
Goodwill, Impairment Loss
Impairment of goodwill
Goodwill
Goodwill
Goodwill
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
In-process research and development
In Process Research and Development [Member]
Income Tax Authority, Name [Domain]
Income Tax Authority, Name [Axis]
Condensed Consolidated Statements of Operations
INCOME TAXES
Provision for income taxes
Income Tax Expense (Benefit)
INCOME TAXES
Income Tax Disclosure [Text Block]
Income taxes
Income Tax, Policy [Policy Text Block]
Increase (Decrease) in Accounts Payable
Accounts payable
Accrued expenses and other liabilities
Increase (Decrease) in Accrued Liabilities
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities
Increase (Decrease) in Prepaid Expense
Prepaid expenses
Increase (Decrease) in Stockholders' Equity
Increase (Decrease) in Stockholders' Equity [Roll Forward]
In-process research and development
Intangible Assets, Net (Excluding Goodwill)
Interest expense
Interest Expense, Related Party
Coupon interest
Interest Expense, Debt, Excluding Amortization
Accrued interest
Interest payable
Interest Payable, Current
Accrued interest payable
Accretion of discount
Interest expense
Interest Expense
Interest expense
Federal
Internal Revenue Service (IRS) [Member]
Interest income
Investment Income, Interest
Investor
Investor [Member]
IPO
IPO [Member]
Total current liabilities
Liabilities, Current
Total liabilities and stockholders' equity
Liabilities and Equity
Current liabilities
Liabilities, Current [Abstract]
Total liabilities
Liabilities
Liabilities and Stockholders' Equity
Liabilities and Equity [Abstract]
Loans payable
Loans Payable, Current
Balance outstanding
Loans payable
Loans Payable [Member]
Maximum
Maximum [Member]
Minimum
Minimum [Member]
NATURE OF OPERATIONS AND LIQUIDITY
Nature of Operations [Text Block]
Cash flows from financing activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash flows from operating activities
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net (decrease) increase in cash and cash equivalents
Net Cash Provided by (Used in) Continuing Operations
Net loss
Net Income (Loss) Available to Common Stockholders, Basic
Net loss
Net Cash Provided by (Used in) Operating Activities, Continuing Operations
Net cash used in operating activities
Net Cash Provided by (Used in) Financing Activities, Continuing Operations
Net cash provided by financing activities
Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Net cash provided by investing activities
Cash flows from investing activities:
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
New jersey
New Jersey Division of Taxation [Member]
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Noncash or Part Noncash Acquisition, Value of Assets Acquired [Abstract]
Less assets acquired:
Noncash or Part Noncash Acquisition, Value of Liabilities Assumed [Abstract]
Plus liabilities assumed:
Noncash or Part Noncash Acquisition, Payables Assumed
Accrued expenses and other
Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Equipment
Over-allotment
Over-Allotment Option [Member]
Expenses
Operating Expenses [Abstract]
Total expenses
Operating Expenses
Operating Income (Loss)
Loss from operations
Operating Loss Carryforwards [Table]
Net operating losses
Operating Loss Carryforwards [Line Items]
Net operating losses
Operating Loss Carryforwards
Other Commitments [Table]
Other Commitments [Axis]
Commitments
Other Commitments [Line Items]
Other Commitments [Domain]
Products and Services [Domain]
ACCRUED EXPENSES AND OTHER LIABILITIES
Stock issuance expenses
Payments of Stock Issuance Costs
Public offering costs paid
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Prepaid expenses
Prepaid Expense, Current
Private placement
Private Placement [Member]
Proceeds from Issuance Initial Public Offering
Net proceeds from IPO
Proceeds from Issuance of Common Stock
Proceeds from sales of common stock
Net proceeds from sale of common stock
Net proceeds from issuance of common stock
Proceeds from working capital loans
Proceeds from Short-term Debt
Products and Services [Axis]
Equipment, net
Property, Plant and Equipment, Net
Range [Axis]
Range [Domain]
RELATED PARTY TRANSACTIONS
Related Party Transactions Disclosure [Text Block]
Related party transactions
Related Party Transaction [Line Items]
Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party
Related party expenses
Related Party [Axis]
Related Party [Domain]
RELATED PARTY TRANSACTIONS
Repayments of working capital loans
Repayments of Short-term Debt
Repayment of the bridge loans
Loans repayment
Counterparty Name [Domain]
Research and development
Research and Development Expense
Research and development costs
Research and Development Expense, Policy [Policy Text Block]
Federal research and development
Research Tax Credit Carryforward [Member]
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated Deficit
Retained Earnings [Member]
Vesting percentage
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage
Expected term
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term
Term of share-based award
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period
Weighted average fair value of stock options granted (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Exercise price of options granted (in dollars per share)
Weighted average contractual term of the options outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Sale of Stock [Domain]
Schedule of assets acquired and liabilities assumed
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Schedule of securities outstanding excluded from the calculation of weighted average shares outstanding
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of stock option activity
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of accrued expenses and other liabilities
Schedule of Accrued Liabilities [Table Text Block]
Schedule of computation of basic and diluted loss per share for common stockholders
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Business Acquisitions, by Acquisition [Table]
Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]
Schedule of Related Party Transactions, by Related Party [Table]
Schedule of Short-term Debt [Table]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Weighted-Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Exercise price of options granted (in dollars per share)
Volatility, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Volatility, minimum (as a percent)
Share-based Compensation
Stock-based compensation expense
Risk free interest rate, maximum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Vesting period
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period
Number of common shares to be issued for options granted
Number of shares for which option to purchase is granted
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Granted (in shares)
Stock option plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price
Share price (in dollars per share)
Share fair value (in dollars per share)
Risk free interest rate, minimum (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Exercisable at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Dividend yield (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Exercisable at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Additional disclosure
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Volatility (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Risk free interest rate (as a percent)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Assumptions used in fair value of each stock option to purchase common stock using the Black-Scholes option pricing model
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair value of common stock on grant date (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Outstanding at the beginning of period (in dollars per share)
Outstanding at the end of the period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-based compensation
Outstanding at the beginning of period (in shares)
Outstanding at the end of the period (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Number of stock options (in shares)
Number of shares issued
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
Intrinsic value of outstanding stock options (in dollars)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Equity Award [Domain]
Balance (in shares)
Balance (in shares)
Shares, Issued
Convertible Promissory Notes
DEBT
Short-term Debt [Line Items]
Short-term Debt, Type [Domain]
Short-term Debt, Type [Axis]
SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies [Text Block]
Statement [Table]
Statement
Statement [Line Items]
Consolidated Statements of Stockholders' Equity
Condensed Consolidated Statements of Cash Flows
Equity Components [Axis]
Condensed Consolidated Balance Sheets
Issuance of shares for business acquisition (in shares)
Stock Issued During Period, Shares, Acquisitions
Assumed in merger (in shares)
Issuance of shares for business acquisition
Stock Issued During Period, Value, Acquisitions
Stock Issued
Common stock issued as consideration for business acquisition
Stock Issued During Period, Shares, New Issues
Issued (in shares)
Sale of common stock (in shares)
Common stock issued (in shares)
Vesting of common shares issued
Stock Issued During Period, Value, Share-based Compensation, Gross
Stock Issued During Period, Shares, Share-based Compensation, Gross
Vesting of common shares issued (in shares)
Number of shares remitted
Stock Repurchased During Period, Shares
Stockholders' equity
Stockholders' Equity Attributable to Parent [Abstract]
Balance
Total stockholders' equity
Stockholders' Equity Attributable to Parent
Balance
STOCKHOLDERS' EQUITY
Stockholders' Equity Note Disclosure [Text Block]
STOCKHOLDERS' EQUITY
Conversion ratio
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split ratio
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Subsequent Event [Table]
Subsequent events
Subsequent Event [Line Items]
Subsequent event
Subsequent Event [Member]
Subsequent Event Type [Domain]
Subsequent Event Type [Axis]
Sale of Stock [Axis]
Tax Credit Carryforward [Table]
Credits
Tax Credit Carryforward, Amount
Tax Credit Carryforward, Name [Domain]
Credits
Tax Credit Carryforward [Line Items]
Tax Credit Carryforward [Axis]
Title of Individual [Axis]
Relationship to Entity [Domain]
Type of Arrangement and Non-arrangement Transactions [Axis]
Unrealized Gain (Loss) on Derivatives
Change in fair value of derivative
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Interest or penalties related to income taxes
Use of estimates
Use of Estimates, Policy [Policy Text Block]
Weighted-average shares of common stock outstanding
Weighted Average Number of Shares Outstanding, Basic and Diluted
Weighted average shares outstanding, basic and diluted (in shares)